Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.36 Million | 3.08 Million | 1.63 Million | 1.12 Million | 679.62 Thousand |
| Cost of Revenue | 366.76 Thousand | 217.15 Thousand | 187.67 Thousand | 295.63 Thousand | 200.81 Thousand | 56.08 Thousand |
| Gross Profit | -366.76 Thousand | 4.14 Million | 2.89 Million | 1.34 Million | 920.9 Thousand | 623.53 Thousand |
| Operating Expenses | 21.68 Million | 17.1 Million | 13.96 Million | 15.06 Million | 5.2 Million | 3.36 Million |
| Selling, General and Administrative Expenses | 21.68 Million | 17.1 Million | 13.96 Million | 15.06 Million | 5.2 Million | 3.36 Million |
| Research and Development Expenses | - | 7.16 Million | 6.22 Million | 5.55 Million | 1.98 Million | 416.35 Thousand |
| Other Expenses | - | 4.28 Million | 1.53 Million | 1.59 Million | 974.23 Thousand | 571.33 Thousand |
| Cost and Expenses | 22.05 Million | 17.32 Million | 14.15 Million | 15.36 Million | 5.4 Million | 3.41 Million |
| Operating Income | -22.05 Million | -17.32 Million | -14.15 Million | -15.36 Million | -5.4 Million | -3.41 Million |
| Interest Expense | 846.85 Thousand | 183.26 Thousand | 11.92 Thousand | 12.14 Thousand | 56.44 Thousand | 56.69 Thousand |
| Income Tax Expense | -4.9 Million | -4.31 Million | -3.08 Million | -1.56 Million | -1.07 Million | -679.62 Thousand |
| Earnings before Tax | -22.56 Million | -17.38 Million | -14.07 Million | -15.07 Million | -5.38 Million | -3.46 Million |
| Net Income | -17.66 Million | -13.07 Million | -10.98 Million | -13.51 Million | -4.31 Million | -2.78 Million |
| Earnings Per Share Basic | -0.10 | -0.07 | -0.06 | -0.09 | -0.03 | -0.03 |
| Earnings Per Share Diluted | -0.10 | -0.07 | -0.06 | -0.09 | -0.03 | -0.03 |
| Weighted Average Shares Outstanding | 177.09 Million | 175.71 Million | 175.87 Million | 156.95 Million | 128.47 Million | 95.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 177.09 Million | 175.71 Million | 175.87 Million | 156.95 Million | 128.47 Million | 95.41 Million |
| Gross Margin | - | 0.95 | 0.94 | 0.82 | 0.82 | 0.92 |
| EBIT Margin | - | -3.92 | -4.53 | -9.20 | -4.64 | -4.95 |
| Profit Margin | - | -3.00 | -3.56 | -8.25 | -3.85 | -4.10 |
| EBITDA | -21.35 Million | -16.98 Million | -10.79 Million | -14.77 Million | -5.13 Million | -2.67 Million |
| Earnings Before Tax Margin | - | -3.97 | -4.59 | -9.38 | -4.82 | -5.03 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 2.38 Million | 4.36 Million | 4.36 Million | - |
| Cost of Revenue | 366.76 Thousand | 173.48 Thousand | 193.28 Thousand | 217.15 Thousand | 141.87 Thousand | 75.28 Thousand |
| Gross Profit | -366.76 Thousand | -173.48 Thousand | 2.18 Million | 4.14 Million | 4.22 Million | -75.28 Thousand |
| Operating Expenses | 21.68 Million | 12.27 Million | 9.41 Million | 17.1 Million | 7.92 Million | 9.17 Million |
| Selling, General and Administrative Expenses | - | 12.27 Million | 9.41 Million | - | 7.92 Million | 9.17 Million |
| Research and Development Expenses | - | - | 4.72 Million | - | 3.08 Million | 4.08 Million |
| Other Expenses | - | - | - | 4.28 Million | - | - |
| Cost and Expenses | 22.05 Million | 12.44 Million | 9.6 Million | 17.32 Million | 8.07 Million | 9.25 Million |
| Operating Income | -22.05 Million | -12.44 Million | -9.6 Million | -17.32 Million | -8.07 Million | -9.25 Million |
| Interest Expense | 846.85 Thousand | 572.43 Thousand | 274.41 Thousand | 183.26 Thousand | 177.03 Thousand | 6229.00 |
| Income Tax Expense | -4.9 Million | -2.62 Million | -2.28 Million | -4.31 Million | -4.31 Million | 5.00 |
| Earnings before Tax | -22.56 Million | -12.82 Million | -9.74 Million | -17.38 Million | -8.16 Million | -9.22 Million |
| Net Income | -17.66 Million | -10.19 Million | -7.46 Million | -13.07 Million | -3.85 Million | -9.22 Million |
| Earnings Per Share Basic | - | -0.05 | -0.04 | - | -0.02 | -0.05 |
| Earnings Per Share Diluted | - | -0.05 | -0.04 | - | -0.02 | -0.05 |
| Weighted Average Shares Outstanding | 177.09 Million | 203.98 Million | 179.37 Million | 175.71 Million | 180.03 Million | 177.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 177.09 Million | 203.98 Million | 179.37 Million | 175.71 Million | 180.03 Million | 177.16 Million |
| Gross Margin | - | - | 0.92 | 0.95 | 0.97 | - |
| EBIT Margin | - | - | -3.95 | - | -1.82 | - |
| Profit Margin | - | - | -3.13 | -3.00 | -0.88 | - |
| EBITDA | - | -12.27 Million | -9.41 Million | - | -7.92 Million | -9.17 Million |
| Earnings Before Tax Margin | - | - | -4.03 | -3.97 | -1.85 | - |
ORKT
CVO
ARQQ
EIQ
SFM
APEX